Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma.

Tennstedt P, Fresow R, Simon R, Marx A, Terracciano L, Petersen C, Sauter G, Dikomey E, Borgmann K.

Int J Cancer. 2013 May 1;132(9):2118-26. doi: 10.1002/ijc.27907. Epub 2012 Nov 5.

2.

Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.

Dihlmann S, Tao S, Echterdiek F, Herpel E, Jansen L, Chang-Claude J, Brenner H, Hoffmeister M, Kloor M.

Int J Cancer. 2014 Nov 15;135(10):2387-96. doi: 10.1002/ijc.28891. Epub 2014 Apr 28.

3.

Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.

Li Y, Yu H, Luo RZ, Zhang Y, Zhang MF, Wang X, Jia WH.

J Surg Oncol. 2011 Nov 1;104(6):617-22. doi: 10.1002/jso.22018. Epub 2011 Jul 8.

PMID:
21744352
4.

Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma.

Elzagheid A, Emaetig F, Buhmeida A, Laato M, El-Faitori O, Syrjänen K, Collan Y, Pyrhönen S.

Tumour Biol. 2013 Apr;34(2):621-8. doi: 10.1007/s13277-012-0588-8. Epub 2012 Nov 21.

PMID:
23179399
5.

Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.

Koelzer VH, Huber B, Mele V, Iezzi G, Trippel M, Karamitopoulou E, Zlobec I, Lugli A.

Hum Pathol. 2015 Nov;46(11):1573-81. doi: 10.1016/j.humpath.2015.07.010. Epub 2015 Jul 29.

PMID:
26351067
6.

Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.

Melling N, Simon R, Izbicki JR, Terracciano LM, Bokemeyer C, Sauter G, Marx AH.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7009-15. eCollection 2015.

7.

A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.

Cheah PY, Choo PH, Yao J, Eu KW, Seow-Choen F.

Cancer. 2002 Dec 15;95(12):2479-86.

8.

Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.

Yoo PS, Sullivan CA, Kiang S, Gao W, Uchio EM, Chung GG, Cha CH.

Ann Surg Oncol. 2009 Jan;16(1):200-7. doi: 10.1245/s10434-008-0209-3. Epub 2008 Nov 14.

PMID:
19009247
9.

High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.

Deng Y, Kurland BF, Wang J, Bi J, Li W, Rao S, Lan P, Lin T, Lin E.

Am J Clin Oncol. 2009 Jun;32(3):245-52. doi: 10.1097/COC.0b013e3181891326.

PMID:
19451802
10.

Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.

Kevans D, Wang LM, Sheahan K, Hyland J, O'Donoghue D, Mulcahy H, O'Sullivan J.

Int J Surg Pathol. 2011 Dec;19(6):751-60. doi: 10.1177/1066896911414566. Epub 2011 Jul 26.

PMID:
21791486
11.
12.

SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential.

Tian YF, Chen TJ, Lin CY, Chen LT, Lin LC, Hsing CH, Lee SW, Sheu MJ, Lee HH, Shiue YL, Huang HY, Pan HY, Li CF, Chen SH.

Tumour Biol. 2013 Apr;34(2):1107-17. doi: 10.1007/s13277-013-0652-z. Epub 2013 Jan 18.

PMID:
23328995
13.

Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.

Yanagawa N, Leduc C, Kohler D, Saieg MA, John T, Sykes J, Yoshimoto M, Pintilie M, Squire J, Shepherd FA, Tsao MS.

J Thorac Oncol. 2012 Oct;7(10):1513-21.

14.

Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.

Wangefjord S, Brändstedt J, Lindquist KE, Nodin B, Jirström K, Eberhard J.

Diagn Pathol. 2013 Jan 21;8:10. doi: 10.1186/1746-1596-8-10.

15.

Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.

Paik SS, Jang KS, Song YS, Jang SH, Min KW, Han HX, Na W, Lee KH, Choi D, Jang SJ.

Ann Surg Oncol. 2007 Dec;14(12):3453-9. Epub 2007 Sep 20.

PMID:
17882496
16.

Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.

Sun X, Sun Z, Zhu Z, Li C, Zhang J, Xu H, Sun M.

Tumour Biol. 2015 Sep;36(10):7521-30. doi: 10.1007/s13277-015-3470-7. Epub 2015 Apr 26.

PMID:
25913622
17.

Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage.

Manne U, Jhala NC, Jones J, Weiss HL, Chatla C, Meleth S, Suarez-Cuervo C, Grizzle WE.

Clin Cancer Res. 2004 Mar 1;10(5):1743-52.

18.

FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.

Garouniatis A, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, Papavassiliou AG.

Int J Colorectal Dis. 2013 Jan;28(1):9-18. doi: 10.1007/s00384-012-1520-9. Epub 2012 Jun 26.

PMID:
22733437
19.

Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.

Lugli A, Vlajnic T, Giger O, Karamitopoulou E, Patsouris ES, Peros G, Terracciano LM, Zlobec I.

Hum Pathol. 2011 Dec;42(12):1833-40. doi: 10.1016/j.humpath.2011.02.010. Epub 2011 Jun 12.

PMID:
21664647
20.

Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.

Lugli A, Tzankov A, Zlobec I, Terracciano LM.

Mod Pathol. 2008 Nov;21(11):1403-12. doi: 10.1038/modpathol.2008.117. Epub 2008 Jun 27.

Items per page

Supplemental Content

Write to the Help Desk